About TFBS About TFBS
About TFBS
CDMO CDMO
CDMO
Testing Testing
Testing
The Japan Times-Cost-effective and reliable services for GMP
The Japan Times-Cost-effective and reliable services for GMP

TFBS Bioscience is included in the list of “CDMO Companies for Regenerative Medicine Products” Released by METI

2025-04-30

TFBS Bioscience is included in the list of “CDMO Companies for Regenerative Medicine Products” Released by METI

We are pleased to announce that TFBS Bioscience LLC was included in the list of “CDMO Companies for Regenerative Medicine Products” recently published by Japan’s Ministry of Economy, Trade and Industry (METI).

This list was jointly compiled by METI and the Forum for Innovative Regenerative Medicine (FIRM), with the goal of facilitating sourcing and collaboration for academic institutions and biotech ventures in drug development, which require process development and manufacturing services from CDMOs in the fields of regenerative medicine, cell therapy, and gene therapy.

For more information, please refer to the list available on FIRM’s official website.

CDMO Companies for Regenerative Medicine Products

Contact:

TFBS Bioscience Inc.
service@tfbsbio.com

    Share :

    BACK